Discover 376 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 376
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Location: Norfolk VA, Raleigh NC, Fairfax VA, Cary NC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase1, Phase2, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Norfolk VA, Raleigh NC, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase3, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Norfolk VA, Newark DE, Winston-Salem NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase3, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Norfolk VA, Fairfax VA, Durham NC, Columbia MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Norfolk VA, Fairfax VA, Durham NC, Silver Spring MD,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Norfolk VA, Silver Spring MD, Allentown PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase2, Phase3, Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Norfolk VA, Durham NC, Hackensack NJ, Buffalo NY,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT07188558
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for
Colorectal Cancer
Location: Norfolk VA, Salem VA, Philadelphia PA, Columbus OH,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06948448
Phase2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Norfolk VA, Midlothian VA, Charlottesville VA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for
HER2-positive Breast Cancer, Breast Cancer
Location: Norfolk VA, Fairfax VA, Laurel MD, Winchester VA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102381
Phase2, Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Norfolk VA, Washington D.C. DC, Philadelphia PA,
Sponsor: Allotera Therapeutics
Sex: All
Age: 0+
Code: NCT06514794
Phase2, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Norfolk VA, Fairfax VA, Wytheville VA, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase3, Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Norfolk VA, Columbia MD, Salem VA, Wynnewood PA,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Norfolk VA, Midlothian VA, Baltimore MD, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
for
Solid Tumors
Location: Norfolk VA, Fairfax VA, Philadelphia PA, New York NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06885281
Phase1, Phase2, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Norfolk VA, Winchester VA, Newark DE, York PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase3, Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
for
Multiple Myeloma
Location: Norfolk VA, Washington D.C. DC, Durham NC, Baltimore MD,